Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in Cutibacterium acnes

dc.contributor.authorGhannoum, Mahmoud
dc.contributor.authorGamal, Ahmed
dc.contributor.authorKadry, Ahmed
dc.contributor.authorDel Rosso, James Q.
dc.contributor.authorStein Gold, Linda
dc.contributor.authorKircik, Leon H.
dc.contributor.authorHarper, Julie C.
dc.contributor.departmentDermatology, School of Medicine
dc.date.accessioned2025-05-20T10:31:04Z
dc.date.available2025-05-20T10:31:04Z
dc.date.issued2025-03-31
dc.description.abstractBackground: Antibiotic resistance is growing globally, with multiple countries reporting resistance in >50% of Cutibacterium acnes (C. acnes) strains. Combination formulations of an antibiotic and the antimicrobial benzoyl peroxide (BPO) may reduce this resistance risk, especially with prolonged use. This 4-part study tested susceptibility of 31 C. acnes clinical strains and development of resistance to antibiotics alone or combined with BPO. Methods: C. acnes susceptibility to single-drug antibiotics was assessed via minimum inhibitory concentration (MIC) values obtained from epsilometer tests, with lower MIC indicating higher susceptibility. Susceptibility to fixed-dose antibiotic/BPO combination products was determined by measuring the zone of inhibition using the agar diffusion method, with larger diameter indicating increased bacterial inhibition. The effect (synergistic, additive, antagonistic, or indifferent [no interaction]) of combining clindamycin with BPO on C. acnes inhibition was evaluated using a checkerboard assay, wherein 2 test compounds are combined in varying concentrations. Resistance development was assessed using serial passage of bacterial cultures in increasing concentrations of clindamycin alone or in combination with BPO. Results: All tested antibiotics (clindamycin, doxycycline, erythromycin, and minocycline) exhibited similar activity. C. acnes susceptibility was variable, with some strains having elevated MIC values-an indication of resistance-against different antibiotics. For 6 strains resistant to clindamycin alone (inhibitory zone=0 cm), formulations with BPO enhanced activity against the same isolates (range: 0.8-2.2 cm). Of 7 acne-associated strains, combining clindamycin and BPO had an additive effect against 4, and no interaction against 3. Bacterial cultures repeatedly exposed to the combination of clindamycin and BPO did not develop antibiotic resistance, which occurred with exposure to clindamycin alone. Conclusion: Overall, antibiotic susceptibility was highly dependent on the C. acnes strain, and antibiotic formulations with BPO exhibited enhanced activity against less susceptible strains. Fixed combinations of BPO with an antibiotic may improve antimicrobial activity and protect against resistance development.
dc.eprint.versionFinal published version
dc.identifier.citationGhannoum M, Gamal A, Kadry A, et al. Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in Cutibacterium acnes. Clin Cosmet Investig Dermatol. 2025;18:755-766. Published 2025 Mar 31. doi:10.2147/CCID.S506254
dc.identifier.urihttps://hdl.handle.net/1805/48258
dc.language.isoen_US
dc.publisherDove Press
dc.relation.isversionof10.2147/CCID.S506254
dc.relation.journalClinical, Cosmetic and Investigational Dermatology
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePMC
dc.subjectAcne
dc.subjectAntibiotics
dc.subjectBenzoyl peroxide
dc.subjectClindamycin
dc.subjectCombination treatment
dc.subjectC. acnes
dc.subjectResistance
dc.subjectSusceptibility
dc.titleCriticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in Cutibacterium acnes
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ghannoum2025Criticality-CCBYNC.pdf
Size:
6.63 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: